Abstract:Objective: To establish a labeling method for a specific lung cancer-targeting small molecule peptide cNGQGEQc with ¹³¹I and observe the radioactivity distribution of the labeled peptide in rabbits using single-photon emission computed tomography (SPECT). Methods: Chloramine-T method was used for ¹³¹I labeling of the tyrosine amino group on cNGQGEQc, and the labeling efficiency and radiochemical purity of ¹³¹I-cNGQGEQc were determined with paper chromatography. The stability of ¹³¹I-cNGQGEQc in saline and human serum was assessed after incubation in water bath at 37 degrees celsius; for 24 h. The octanol-water partition coefficient lg P (the radioactivity counting ratio of ¹³¹I-cNGQGEQc dissolved in 100 µl octanol or in 100 µl saline) was calculated. SPECT was performed in 3 male New Zealand white rabbits after intravenous injection of ¹³¹I-cNGQGEQc to observe the dynamic distribution of the peptide with the time-radioactivity curve (T-A curve) of the region of interest (ROI). Results: With a labeling efficiency of 90%, ¹³¹I-cNGQGEQc showed a radiochemical purity of was 95% after purification with HPLC. The radiochemical purity of ¹³¹I-cNGQGEQc was (93.12 ± 1.18)% and (88.34 ± 5.43)% after intubation in saline and human serum for 24 h, respectively. The octanol-water partition coefficient lg P of ¹³¹I-cNGQGEQc was -1.75, suggesting its hydrosolubility. In rabbits with intravenous injection of ¹³¹I-cNGQGEQc, SPECT visualized the kidneys at 1 min after the injection; the imaging of the heart and liver became attenuated at 5 min when the bladder was visualized with an increasing radioactivity. The radioactivity of the soft tissues began to fade at 30 min. No gallbladder visualization was detected, and the radioactivity of the abdomen remained low. No obvious radioactivity concentration was observed in the thyroid and stomach. The T-A curves of the ROI of all the tissues and organs descended over time. Conclusion: Radiolabeling of cNGQGEQc with ¹³¹I is simple and highly efficient. ¹³¹I-cNGQGEQc has good stability in vitro and good distribution characteristics for in vivo imaging, and is cleared mainly by renal excretion due to its hydrosolubility. These results provide experimental basis for further studies of diagnosis and therapy of lung cancer with targeting polypeptide.

Radiolabeling of Magnetic Nanoparticles with 188re for Magnetic Targeted Radiotherapy

Preparation and Radiolabeling of Surface-Modified Magnetic Nanoparticles with Rhenium-188 for Magnetic Targeted Radiotherapy

~(188)Re labeling and biodistribution of magnetic nanoparticles for the tumor targeting

Labeling HAS-Coated Magnetite Nanoparticals with Rhenium-188 for Tumor Target Therapy

^188 Re Labeled MPEG-modified Superparamagnetic Nanogels：preparation and Preliminary Application in Mice

Preparation and radiolabeling of human serum albumin (HSA)-coated magnetite nanoparticles for magnetically targeted therapy.

Preparation of (188re) Re-AEDP and Its Biodistribution Studies.

Biodistribution of 188Re-Aedp in Rats and Its Dependenceon Rhenium Carrier

Radiolabeling of MAG3-morpholino Oligomers with 188re at High Labeling Efficiency and Specific Radioactivity for Tumor Pretargeting.

Synthesis of amino-modified magnetite nanoparticles coated with Hepama-1 and radiolabeled with 188 Re for bio-magnetically targeted radiotherapy

Anti-tumor Effect in Vitro of ~(188)re Labeled Herceptin-coated Magnetite Nanoparticles

Recombinant metallothionein-conjugated streptavidin labeled with 188Re and 99mTc

Anchoring Group Mediated Radiolabeling for Achieving Robust Nanoimaging Probes

<SUP>177</SUP>Lu Radiolabelled AIE Dots for Multimodal Imaging Guided Photothermal/Radiopharmaceutical Tumor Therapy

Anti-tumor effect in vitro of 188Re labeled Herceptin-coated magnetite nanoparticles

Radiolabeling, Characteristics and NanoSPECT/CT Imaging of 188Re-cetuximab in NCI-H292 Human Lung Cancer Xenografts

188 Re-LABELED HYPERBRANCHED POLYSULFONAMINE AS A ROBUST TOOL FOR TARGETED CANCER DIAGNOSIS AND RADIOIMMUNOTHERAPY

Application Analysis of 124I-PPMN for Enhanced Retention in Tumors of Prostate Cancer Xenograft Mice.

[Radiolabelling of a lung cancer-targeting small molecule polypeptide with (131)I and its radioactivity distribution in normal rabbits]

Radiolabeling and Evaluation of Re-188-Rgd As an Agent for Alpha(V)Beta(3) Receptor Expression

188Re Radiolabeling RGD Peptide and Preliminary Biodistribution Evaluation in Mice Bearing S180 Tumors